Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Prediction of clinical outcome after cardiac arrest is clinically important.Early prognostication after successful cardiopulmonary resuscitation is difficult, and there is a need for novel methods to estimate the extent of brain injury and predict outcome. In this study, the investigators will evaluate the plasma levels of microRNAs (miRNAs) and circRNAs after cardiac arrest and assessed their ability to prognosticate neurological outcome.
4.2 Cerebral Performance Category (CPC) CPC is a 5-category scale for measuring neurological status 2 weeks after cardiac arrest and CPC score 6 months after cardiac arrest. The 5 categories are: CPC 1, conscious and alert with good cerebral performance; CPC 2, conscious and alert with moderate cerebral performance; CPC 3, conscious with severe cerebral disability; CPC 4, comatose or in persistent vegetative state; and CPC 5, brain dead, circulation preserved.
4.3 Sample collection and processing Whole blood sample was collected into Ethylene diamine tetra-acetic acid (EDTA) -anticoagulant tube from each patient immediately at the beginning of CPR, 24h, 48h and 7 days after cardiac arrest. Samples were centrifugated and the supernatant was stored in EP tube with out RNA enzyme at -80 degree Celsius.
4.4 Detection of miRNA and circRNA Patients were divided into two groups according to the Cerebral Performance Category (CPC) after half a year, "CPC 1-2 Group" and "CPC 3-5 Group". Five samples for 48h time point in each group were randomly selected and detected miRNA and circRNA with chips.The real-time quantitative PCR were used to detect the quantity of the selected miRNAs and circRNAs for each time point. The plasma concentration of NSE for each time point was tested by laboratory department.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| CPC score 1 to 2 | The patients with CPC score 1 to 2 judged half a year after cardiac arrest | ||
| CPC scores 3 to 5 | The patients with CPC score 3 to 5 judged half a year after cardiac arrest |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| cerebral performance Category(CPC) of Participants | up to 6 months after cardiopulmonary resuscitation |
| Measure | Description | Time Frame |
|---|---|---|
| survival of participants | up to 28 days after hospitalization | |
| cerebral performance Category(CPC) of Participants | up to 2 weeks after cardiopulmonary resuscitation |
Not provided
1 Inclusion criteria:
2 Exclusion criteria:
Not provided
Not provided
transferred to or hospitalized in the emergency department or other wards of Shanghai Tenth People's Hospital due to cardiac arrest
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Yuanzhuo Chen, MD | Contact | +821666304586 | chenyuanzhuo021@hotmail.com | |
| Wenjie Li, MD | Contact | kingnever@hotmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Yuanzhuo Chen, MD | Shanghai 10th People's Hospital | Study Chair |
| Wenjie Li, MD | Shanghai 10th People's Hospital | Principal Investigator |
| Huiqi Wang, MD |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Shanghai Tenth Hospital | Recruiting | Shanghai | 200000 | China |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 32293300 | Derived | Zhuang YG, Chen YZ, Zhou SQ, Peng H, Chen YQ, Li DJ. High plasma levels of pro-inflammatory factors interleukin-17 and interleukin-23 are associated with poor outcome of cardiac-arrest patients: a single center experience. BMC Cardiovasc Disord. 2020 Apr 15;20(1):170. doi: 10.1186/s12872-020-01451-y. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006323 | Heart Arrest |
| ID | Term |
|---|---|
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Plasma samples are to be retained.
| Shanghai 10th People's Hospital |
| Principal Investigator |
| Chengjin Gao, MD | Shanghai 10th People's Hospital | Study Director |
| Hu Peng, MD | Shanghai 10th People's Hospital | Study Director |
| Yugang Zhuang, MD | Shanghai 10th People's Hospital | Principal Investigator |
| Xiangyu Zhang, MD | Shanghai 10th People's Hospital | Study Director |
| Qixing Wang | Shanghai 10th People's Hospital | Principal Investigator |